In the News

01/11/2018

Best of CES2018: This Year's Showstopping Gadgets

Mouthguards aren’t fun to wear, but they’re an important part of keeping kids safe while playing football, ice hockey, or any kind of potentially concussive sport. Prevent Biometrics’ head impact monitoring mouthguard is unlike any we've seen. 


01/10/2018

Prevent Biometrics® Announces Commercial Launch of Head Impact Monitor System, Bringing Advanced Real-Time Monitoring of Concussion Impacts to Sports

Prevent Biometrics, the Cleveland Clinic spinoff that created the first and only head impact monitoring technology to accurately detect potential concussion-causing impacts in real time, announces its newest innovation at the Consumer Electronics Show today: the Gen 1.2 Head Impact Monitor System, bringing advanced, never-before-available head impact analytic capabilities to schools, associations, teams and coaches. 


01/04/2018

Centerline Biomedical Completes Fifth Preclinical Study

As Centerline Biomedical, Inc. prepares to meet with investors, strategic partners and companies in the healthcare industry during the JP Morgan Healthcare Conference, it successfully completed a fifth preclinical study at Cleveland Clinic facilities evaluating its surgical navigation system, IOPS, the Intra-Operative Positioning System.


12/01/2017

Quest Diagnostics finalizes purchase of Cleveland Clinic spinoff Cleveland HeartLab

Quest Diagnostics today finalized its acquisition of Cleveland Clinic spinoff Cleveland HeartLab. 


11/29/2017

NaviGate Cardiac Structures, Inc. Reports “Exceptional” Six-Week Results for Two Implantations of Its GATE™ Atrioventricular Valved Stent (AVS) to Correct Severe Tricuspid Regurgitation Patients at Ne

NaviGate Cardiac Structures Inc. (“NCSI”) announced today “exceptional results” for implantation of its GATE™ catheter-guided tricuspid atrioventricular valved stent (AVS) at six-week follow-up in two nonagenarian patients presenting with severe tricuspid valve insufficiency.


11/28/2017

Genomic Health and Cleveland Diagnostics Announce Strategic Collaboration to Develop and Commercialize New Prostate Cancer Tests

Genomic Health, Inc. (Nasdaq: GHDX), the world's leading provider of genomic-based diagnostic tests, and Cleveland Diagnostics, Inc., a biotechnology company focused on developing next-generation diagnostics technology for the detection of cancers, today announced an exclusive licensing agreement to develop and commercialize new prostate cancer tests based on Cleveland Diagnostics' IsoPSA™ reagents and technology.


10/24/2017

Cleveland Clinic partners with Silicon Valley accelerator to pilot digital health startups

The Cleveland Clinic has launched a three-year partnership with two technology startups—including one with deep ties to Silicon Valley investors—with a focus on developing new innovative healthcare tools.


10/23/2017

CLE Clinic to Lure Tech Startups to NEO

The city's largest health care employer is making moves to attract health tech startups to the city. 


10/23/2017

Cleveland Clinic and JumpStart Partner to Bring Plug and Play Accelerator to the Global Center for Health Innovation

Cleveland Clinic and JumpStart Inc. have announced a three-year partnership with Silicon Valley's renowned Plug and Play to create an Accelerator focused on biotech and digital health innovation in downtown Cleveland's Global Center for Health Innovation.


10/22/2017

Global innovation firm Plug and Play to partner with Cleveland Clinic, JumpStart on health innovation

Plug and Play, a global business that's nurtured companies like Google, Paypal and Dropbox, is coming to Cleveland.


   <  1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >   

Get In Touch With Us